IDH3α is overexpressed in various human cancer cell lines [161] and cancers [164], and in patients affected by human hepatocellular carcinoma (HCC) [164], lung and breast cancers [161] high levels of IDH3α expression were correlated with a poor prognosis. Here, IDH3A is linked to breast carcinoma.